BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 111 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,286 | -23.0% | 22,051 | +35.5% | 0.00% | – |
| Q2 2023 | $82,158 | +55.4% | 16,269 | -41.8% | 0.00% | – |
| Q1 2023 | $52,871 | -5.9% | 27,974 | -10.3% | 0.00% | – |
| Q4 2022 | $56,164 | -85.5% | 31,202 | -86.4% | 0.00% | – |
| Q3 2022 | $387,000 | -70.7% | 229,189 | -57.3% | 0.00% | – |
| Q2 2022 | $1,319,000 | -3.4% | 536,220 | +8.7% | 0.00% | – |
| Q1 2022 | $1,366,000 | -66.9% | 493,362 | -36.3% | 0.00% | -100.0% |
| Q4 2021 | $4,127,000 | -35.9% | 773,936 | +1.7% | 0.00% | 0.0% |
| Q3 2021 | $6,439,000 | -12.1% | 761,091 | +26.6% | 0.00% | 0.0% |
| Q2 2021 | $7,327,000 | +2255.9% | 601,020 | +4599.9% | 0.00% | – |
| Q1 2021 | $311,000 | -91.3% | 12,788 | -88.5% | 0.00% | -100.0% |
| Q4 2020 | $3,578,000 | +1292.2% | 111,661 | +1212.0% | 0.00% | – |
| Q3 2020 | $257,000 | +59.6% | 8,511 | +123.0% | 0.00% | – |
| Q2 2020 | $161,000 | +360.0% | 3,816 | +170.6% | 0.00% | – |
| Q1 2020 | $35,000 | – | 1,410 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $110,568,000 | 2.92% |
| Boxer Capital, LLC | 2,014,858 | $64,576,000 | 2.08% |
| RA Capital Management | 2,589,904 | $83,006,000 | 1.16% |
| Artal Group S.A. | 1,646,517 | $52,771,000 | 1.13% |
| Burrage Capital Management LLC | 34,891 | $1,118,000 | 0.85% |
| Bellevue Group AG | 1,403,000 | $44,967,000 | 0.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,511 | $25,720,000 | 0.51% |
| Ikarian Capital, LLC | 293,941 | $9,421,000 | 0.42% |
| Avoro Capital Advisors LLC | 640,000 | $20,512,000 | 0.35% |
| Logos Global Management LP | 123,465 | $3,957,000 | 0.34% |